ATE403424T1 - Verwendung von zinkgluconat zur behandlung von hydradenitis suppurativa - Google Patents
Verwendung von zinkgluconat zur behandlung von hydradenitis suppurativaInfo
- Publication number
- ATE403424T1 ATE403424T1 AT06743645T AT06743645T ATE403424T1 AT E403424 T1 ATE403424 T1 AT E403424T1 AT 06743645 T AT06743645 T AT 06743645T AT 06743645 T AT06743645 T AT 06743645T AT E403424 T1 ATE403424 T1 AT E403424T1
- Authority
- AT
- Austria
- Prior art keywords
- zinc gluconate
- treat
- hydradenitis suppurativa
- hydradenitis
- suppurativa
- Prior art date
Links
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 title abstract 3
- 229960000306 zinc gluconate Drugs 0.000 title abstract 3
- 235000011478 zinc gluconate Nutrition 0.000 title abstract 3
- 239000011670 zinc gluconate Substances 0.000 title abstract 3
- 208000002557 hidradenitis Diseases 0.000 title 1
- 201000007162 hidradenitis suppurativa Diseases 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/315—Zinc compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0503695A FR2884420B1 (fr) | 2005-04-13 | 2005-04-13 | Nouvelle utilisation du gluconate de lithium pour le traitement de l'hidradenite suppuree |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE403424T1 true ATE403424T1 (de) | 2008-08-15 |
Family
ID=35522612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06743645T ATE403424T1 (de) | 2005-04-13 | 2006-04-06 | Verwendung von zinkgluconat zur behandlung von hydradenitis suppurativa |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20090215889A1 (de) |
| EP (1) | EP1874291B1 (de) |
| AT (1) | ATE403424T1 (de) |
| AU (1) | AU2006234397B2 (de) |
| BR (1) | BRPI0610524A2 (de) |
| CA (1) | CA2604028A1 (de) |
| DE (1) | DE602006002126D1 (de) |
| ES (1) | ES2308744T3 (de) |
| FR (1) | FR2884420B1 (de) |
| WO (1) | WO2006108949A2 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010313216A1 (en) * | 2009-11-01 | 2012-06-14 | Synthetic Biologics, Inc. | Gastroretentive oral high dose zinc preparations |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4503070A (en) * | 1981-07-31 | 1985-03-05 | Eby Iii George A | Method for reducing the duration of the common cold |
| FR2574295B1 (fr) * | 1984-12-07 | 1988-02-26 | Rech Etu Therapeutiques | Medicaments a base de gluconate de zinc utiles pour le traitement des hyperprolactinemies |
| US5208031A (en) * | 1989-06-06 | 1993-05-04 | Kelly Patrick D | Sexual lubricants containing zinc as an anti-viral agent |
| US6482839B1 (en) * | 1997-06-02 | 2002-11-19 | Cellegy Pharmaceuticals, Inc. | Pyridine-thiols for treatment of a follicular dermatosis |
| US7879365B2 (en) * | 2002-02-07 | 2011-02-01 | The Trustees Of Columbia University In The City Of New York | Zinc salt compositions for the prevention of dermal and mucosal irritation |
-
2005
- 2005-04-13 FR FR0503695A patent/FR2884420B1/fr not_active Expired - Fee Related
-
2006
- 2006-04-06 AT AT06743645T patent/ATE403424T1/de not_active IP Right Cessation
- 2006-04-06 EP EP06743645A patent/EP1874291B1/de not_active Not-in-force
- 2006-04-06 DE DE602006002126T patent/DE602006002126D1/de active Active
- 2006-04-06 US US11/918,317 patent/US20090215889A1/en not_active Abandoned
- 2006-04-06 BR BRPI0610524A patent/BRPI0610524A2/pt not_active IP Right Cessation
- 2006-04-06 CA CA002604028A patent/CA2604028A1/fr not_active Abandoned
- 2006-04-06 ES ES06743645T patent/ES2308744T3/es active Active
- 2006-04-06 WO PCT/FR2006/000761 patent/WO2006108949A2/fr active Application Filing
- 2006-04-06 AU AU2006234397A patent/AU2006234397B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FR2884420B1 (fr) | 2007-07-06 |
| WO2006108949A3 (fr) | 2007-03-29 |
| WO2006108949A2 (fr) | 2006-10-19 |
| DE602006002126D1 (de) | 2008-09-18 |
| CA2604028A1 (fr) | 2006-10-19 |
| AU2006234397A1 (en) | 2006-10-19 |
| BRPI0610524A2 (pt) | 2016-11-16 |
| EP1874291A2 (de) | 2008-01-09 |
| FR2884420A1 (fr) | 2006-10-20 |
| ES2308744T3 (es) | 2008-12-01 |
| EP1874291B1 (de) | 2008-08-06 |
| AU2006234397B2 (en) | 2011-04-07 |
| US20090215889A1 (en) | 2009-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| DE502007002101D1 (de) | Arzneimittel mit Dobesilat-Calcium zur Behandlung und Prophylaxe von Sehnenerkrankungen | |
| DE502005010615D1 (de) | Mittel zur behandlung von entzündlichen erkrankungen | |
| EE200400020A (et) | Asendatud oksasolidinoonid kombineeritud raviks | |
| ATE533484T1 (de) | Verwendung von rotigotin zur behandlung oder zur prävention des dopaminergen neuronenverlustes | |
| DE50311898D1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
| EA200801492A1 (ru) | Фармацевтическое применение замещенных амидов | |
| DE60115842D1 (de) | Ventilanordnung | |
| BRPI0509140A (pt) | processos para o tratamento de infecção por hiv | |
| ATE409176T1 (de) | 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen | |
| ATE389395T1 (de) | Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson | |
| DE60218193D1 (de) | Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesia | |
| DE602004016950D1 (de) | Verwendung von cyclin-d1-hemmern zur brustkrebsbehandlung | |
| ATE429916T1 (de) | Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme | |
| ATE501719T1 (de) | Methoden und zusammensetzungen zur beruhigung von mund- und nasenschleimhäuten | |
| GB0606015D0 (en) | therapeutic agents | |
| ATE380554T1 (de) | Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie | |
| ATE252383T1 (de) | Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
| ATE403424T1 (de) | Verwendung von zinkgluconat zur behandlung von hydradenitis suppurativa | |
| RU2006109966A (ru) | Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных | |
| DE60306503D1 (de) | Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion | |
| EA200600989A1 (ru) | Применение габоксадола для лечения бессонницы | |
| ATE446759T1 (de) | Verwendung von oxcarbazepin zur verbesserung des schlafes bei patienten die an chronischem schmerz leiden | |
| DE60308862D1 (de) | Verbindungen und zusammensetzungen zur behandlung von diabetes und erkrankungen, die mit diabetes in zusammenhang stehen | |
| DE602004025001D1 (de) | Verbindungen zur behandlung von neuropathischen schmerzen und migräne |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |